Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
26 June 2024
m 01:44 | Fostamatinib (Tavalisse) diffhist -3 Jwarner talk contribs |
m 01:43 | Fluorouracil (5-FU) diffhist +1 Warner-admin talk contribs Text replacement - "http://en.wikipedia.org" to "https://en.wikipedia.org" |
m 01:43 | Ibrutinib (Imbruvica) diffhist +1 Warner-admin talk contribs Text replacement - "http://en.wikipedia.org" to "https://en.wikipedia.org" |
m 01:43 | Acalabrutinib (Calquence) diffhist +1 Warner-admin talk contribs Text replacement - "http://en.wikipedia.org" to "https://en.wikipedia.org" |
m 01:43 | Obinutuzumab (Gazyva) diffhist +1 Warner-admin talk contribs Text replacement - "http://en.wikipedia.org" to "https://en.wikipedia.org" |
m 01:43 | Cobimetinib (Cotellic) diffhist +2 Warner-admin talk contribs Text replacement - "http://en.wikipedia.org" to "https://en.wikipedia.org" |
m 01:42 | Trametinib (Mekinist) diffhist +2 Warner-admin talk contribs Text replacement - "http://en.wikipedia.org" to "https://en.wikipedia.org" |
25 June 2024
21 June 2024
m 23:48 | Bevacizumab-adcd (Vegzelga) diffhist +10 Jwarner talk contribs →Also known as |
m 23:47 | Bevacizumab-maly (Alymsys) diffhist +9 Jwarner talk contribs →Also known as |
N 23:42 | Bevacizumab-tnjn (Avzivi) diffhist +4,211 Jwarner talk contribs Created page with "'''Note: this is an FDA-approved biosimilar. The information below is reproduced from the Bevacizumab (Avastin) page, except for the details of FDA indication and the refe..." |
m 21:42 | Afamitresgene Autoleucel (ADP-A2M4) diffhist -4 Jwarner talk contribs →Liposarcoma |
18 June 2024
m 14:15 | Imatinib (Gleevec) diffhist +15 Jwarner talk contribs →Also known as |
|
m 14:08 | Crizotinib (Xalkori) 2 changes history +20 [Jwarner (2×)] | |||
m |
|
14:08 (cur | prev) +11 Jwarner talk contribs →Also known as | |||
m |
|
14:07 (cur | prev) +9 Jwarner talk contribs →Also known as |
|
m 10:54 | Pembrolizumab (Keytruda) 2 changes history +220 [Jwarner (2×)] | |||
m |
|
10:54 (cur | prev) -2 Jwarner talk contribs | |||
m |
|
10:53 (cur | prev) +222 Jwarner talk contribs →Endometrial cancer |
m 00:12 | Lisocabtagene maraleucel (Breyanzi) diffhist 0 Jwarner talk contribs →History of changes in FDA indication |
15 June 2024
m 00:38 | Blinatumomab (Blincyto) diffhist +322 Jwarner talk contribs |
|
m 00:29 | Durvalumab (Imfinzi) 3 changes history +314 [Jwarner (3×)] | |||
m |
|
00:29 (cur | prev) 0 Jwarner talk contribs | |||
m |
|
00:27 (cur | prev) +53 Jwarner talk contribs | |||
m |
|
00:25 (cur | prev) +261 Jwarner talk contribs →History of changes in FDA indication |
13 June 2024
m 21:26 | Repotrectinib (Augtyro) diffhist +444 Jwarner talk contribs →History of changes in FDA indication |
12 June 2024
m 23:00 | Selpercatinib (Retevmo) diffhist +354 Jwarner talk contribs →Thyroid cancer |